Senores Pharmaceuticals Limited (BOM:544319)

Revenue by Product

Financials in millions INR. Fiscal year is April - March.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Regulated Markets	1.45B
Regulated Markets Growth	599.86%
Emerging Markets	442.02M
Application Programming Interface	139.02M
Application Programming Interface Growth	602.83%
Critical Care Injectables	57.10M
Critical Care Injectables Growth	234.90%
Other	55.58M
Other Growth	-49.07%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
International	1.67B
International Growth	460.20%
India	474.29M
India Growth	760.94%